Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Enzo Biochem Inc ENZ

Healthcare
Enzo Biochem, Inc. is focused on molecular diagnostics and has a portfolio of technical platforms and reagent sets supporting a diverse range of biomedical research and translational science needs. The Company operates through the product segment, which manufactures, develops and markets products and tools for clinical research, translational research, drug development and bioscience research... see more

Recent & Breaking News (NYSE:ENZ)

ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE

GlobeNewswire November 6, 2023

Steven J. Pully Appointed to Enzo Biochem's Board of Directors

GlobeNewswire October 30, 2023

Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO

GlobeNewswire September 6, 2023

Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp

GlobeNewswire July 24, 2023

Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results

GlobeNewswire June 14, 2023

Federman & Sherwood Investigates Enzo Biochem for Data Breach

Business Wire June 2, 2023

Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale

GlobeNewswire May 22, 2023

SHAREHOLDER ALERT: Weiss Law Investigates Enzo Biochem, Inc.

PR Newswire May 2, 2023

Enzo Biochem, Inc. Announces Date of Special Meeting of Shareholders

GlobeNewswire April 24, 2023

Enzo Biochem Reports Second Quarter Fiscal Year 2023 Financial Results

GlobeNewswire March 21, 2023

Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp

GlobeNewswire March 16, 2023

Enzo Biochem Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business Update

GlobeNewswire December 12, 2022

Enzo Biochem, Inc. to Report First Quarter Fiscal 2023 Financial Results and Business Update on Monday, December 12th

GlobeNewswire December 7, 2022

Enzo Biochem, Inc. Announces Date of Annual Shareholders' Meeting

GlobeNewswire November 8, 2022

Farmer Bros. Co. Announces Board Refresh and Cooperation Agreement with Stockholders JCP Investment Management and 22NW

GlobeNewswire October 31, 2022

Enzo Biochem, Inc. Appoints Patricia Eckert, CPA as Interim CFO

GlobeNewswire October 20, 2022

Enzo Biochem Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update

GlobeNewswire October 14, 2022

Enzo Biochem to Report Fourth Quarter 2022 Financial Results and Business Update on Friday, October 14th

GlobeNewswire October 10, 2022

Enzo Biochem, Inc. Opens Expanded Life Sciences Laboratory and Office Facilities in Farmingdale, New York

GlobeNewswire October 6, 2022

Enzo Biochem, Inc. Launches AMPIVIEW(TM) Gene Expression Platform with First Products Targeting Detection of HPV and SARS-CoV-2

GlobeNewswire September 26, 2022